Journal of cardiovascular pharmacology and therapeutics

Keyphrases

Publications

volume 28, 2023

Xiao Wang, Zuqing Xu, Rong Chang, Changchun Zeng, Yanli Zhao
High-Fructose Diet Induces Cardiac Dysfunction via Macrophage Recruitment in Adult Mice. Journal of cardiovascular pharmacology and therapeutics 28 (2023)
Koichiro Matsumura, Takeshi Ijichi, Junko Morimoto, Kensuke Takabayashi, Mitsunori Miho, Keisuke Ueno, Eijiro Yagi, Toru Takase, Masafumi Ueno, Gaku Nakazawa
Up-Titration of Sacubitril/Valsartan Among Patients With Heart Failure and Preserved Ejection Fraction. Journal of cardiovascular pharmacology and therapeutics 28 (2023)
Methnani Jabeur, Marwa Hajbelgacem, Taieb Ach, Faten Chaieb, Sana Sellami, Ali Bouslama, Monia Zaouali, Asma Omezzine, Ezdine Bouhlel
Effect of Pre-Meal Metformin With or Without an Acute Exercise Bout on Postprandial Lipemic and Glycemic Responses in Metabolic Syndrome Patients: A Randomized, Open Label, Crossover Study. Journal of cardiovascular pharmacology and therapeutics 28 (2023)
Yuanyuan Zeng, Jing Zhao, Jingfang Zhang, Tingting Yao, Jieqiong Weng, Mengfei Yuan, Xiaoxu Shen
Development of a Nomogram That Predicts the Risk of Coronary Heart Disease in Patients With Hyperlipidemia. Journal of cardiovascular pharmacology and therapeutics 28 (2023)
Zohair A Al Aseri, Farjah H AlGahtani, Majid F Bakheet, Ahmed H Al-Jedai, Sarah Almubrik
Evidence-based Management of Major Bleeding in Patients Receiving Direct Oral Anticoagulants: An Updated Narrative Review on the Role of Specific Reversal Agents. Journal of cardiovascular pharmacology and therapeutics 28 (2023)
Yuanyuan Zeng, Jing Zhao, Jingfang Zhang, Tingting Yao, Jieqiong Weng, Mengfei Yuan, Xiaoxu Shen
Development of a Nomogram That Predicts the Risk of Coronary Heart Disease in Patients With Hyperlipidemia. Journal of cardiovascular pharmacology and therapeutics 28 (2023)
Xueyuan Yang, Chao Feng, Jinping Feng
Epicardial Adipose Tissue and Diabetic Cardiomyopathy. Journal of cardiovascular pharmacology and therapeutics 28 (2023)
João Pedro Faria, Pedro Oliveira, André Alexandre, David Sá Couto, Ricardo Costa, Andreia Campinas, André Frias, Bruno Brochado, Raquel Santos, João Silveira, Severo Torres, André Luz
Ticagrelor Loading on ST-Elevation Myocardial Infarction: Interaction With Prodromal Angina on Infarct Size and Clinical Events. Journal of cardiovascular pharmacology and therapeutics 28 (2023)
Jia Cheng, Lin Qiu, Zixuan Zhang, Na Li, Hongyang Shu, Zhichao Xiao, Ning Zhou
Combination of Nicorandil and Beta-Adrenergic Receptor Blockers in Patients with Coronary Artery Disease: A Real-World Observational Study. Journal of cardiovascular pharmacology and therapeutics 28 (2023)
Yonghong Luo, Daoquan Peng
Residual Atherosclerotic Cardiovascular Disease Risk: Focus on Non-High-Density Lipoprotein Cholesterol. Journal of cardiovascular pharmacology and therapeutics 28 (2023)
Hani Sabbour, Aftab Ahmad
Management of Heart Failure in Patients With Diabetes Mellitus in the UAE: A Call to Action. Journal of cardiovascular pharmacology and therapeutics 28 (2023)
Qian Hao, Zhao Yuanyuan, Chen Lijuan
The Prognostic Value of the Triglyceride Glucose Index in Patients With Acute Myocardial Infarction. Journal of cardiovascular pharmacology and therapeutics 28 (2023)
Maofeng Gong, Qing Zhao, Rui Jiang, Zhengli Liu, Boxiang Zhao, Jie Kong, Xu He, Jianping Gu
Endovascular Therapies Using Catheter-Based Thrombectomy or Catheter-Directed Thrombolysis for Acute Non-Cancer Associated Inferior Vena Cava Thrombosis: A Retrospective Cohort Study. Journal of cardiovascular pharmacology and therapeutics 28 (2023)
Yuanyuan Zeng, Jing Zhao, Jingfang Zhang, Tingting Yao, Jieqiong Weng, Mengfei Yuan, Xiaoxu Shen
Development of a Nomogram That Predicts the Risk of Coronary Heart Disease in Patients With Hyperlipidemia. Journal of cardiovascular pharmacology and therapeutics 28 (2023)
Wangde Dai, Jianru Shi, Prabha Siddarth, Lifu Zhao, Juan Carreno, Michael T Kleinman, David A Herman, Rebecca J Arechavala, Samantha Renusch, Irene Hasen, Amanda Ting, Robert A Kloner
Effects of Electronic Cigarette Exposure on Myocardial Infarction and No-Reflow, and Cardiac Function in a Rat Model. Journal of cardiovascular pharmacology and therapeutics 28 (2023)
Wangde Dai, Jianru Shi, Prabha Siddarth, Lifu Zhao, Juan Carreno, Michael T Kleinman, David A Herman, Rebecca J Arechavala, Samantha Renusch, Irene Hasen, Amanda Ting, Robert A Kloner
Effects of Electronic Cigarette Exposure on Myocardial Infarction and No-Reflow, and Cardiac Function in a Rat Model. Journal of cardiovascular pharmacology and therapeutics 28 (2023)
Methnani Jabeur, Marwa Hajbelgacem, Taieb Ach, Faten Chaieb, Sana Sellami, Ali Bouslama, Monia Zaouali, Asma Omezzine, Ezdine Bouhlel
Effect of Pre-Meal Metformin With or Without an Acute Exercise Bout on Postprandial Lipemic and Glycemic Responses in Metabolic Syndrome Patients: A Randomized, Open Label, Crossover Study. Journal of cardiovascular pharmacology and therapeutics 28 (2023)
Rupert M Bauersachs
Fondaparinux Sodium: Recent Advances in the Management of Thrombosis. Journal of cardiovascular pharmacology and therapeutics 28 (2023)
Jaouad Azzahhafi, Wout W A van den Broek, Dean R P P Chan Pin Yin, Ankie M Harmsze, Ron H N van Schaik, Jurriën M Ten Berg
The Clinical Implementation of CYP2C19 Genotyping in Patients with an Acute Coronary Syndrome: Insights From the FORCE-ACS Registry. Journal of cardiovascular pharmacology and therapeutics 28 (2023)
Byung Jin Kim, Kwang Soo Cha, Wook Hyun Cho, Eung Ju Kim, Seung-Hyuk Choi, Moo Hyun Kim, Sang-Hyun Kim, Jun-Bean Park, Seong-Mi Park, Il Suk Sohn, Kyu Hyung Ryu, In-Ho Chae
Efficacy and Safety of a Single-Pill Triple Combination of Olmesartan, Amlodipine, and Rosuvastatin in Hypertensive Patients with Low-to-Moderate Cardiovascular Risk: A Multicenter, Randomized, Open-Label, Active-Control, Phase IV Clinical Trial. Journal of cardiovascular pharmacology and therapeutics 28 (2023)
Juan A Peraza-Zaldivar, Juan M Ponce-Guarneros, Ernesto G Cardona-Muñoz, Yussef Esparza-Guerrero, Ana M Saldaña-Cruz, Sergio A González-Vazquez, Laura Gonzalez-Lopez, Jorge I Gamez-Nava, Norma Alejandra Rodriguez-Jimenez
Effects of Renin-Angiotensin System Inhibitors on Atrial Mechanics Parameters in Patients with Metabolic Syndrome. Journal of cardiovascular pharmacology and therapeutics 28 (2023)
Noor Muhammad Azlan Shah Bin Atan, Mohd Firdaus Bin Hadi, Victoria Wen Yeng Teoh, Mahmoud Danaee, Alexander Loch
ARNI Versus Perindopril for Remodeling in HFrEF. A Cohort Study. Journal of cardiovascular pharmacology and therapeutics 28 (2023)
Ruslan B Strutynskyi, Nataliіa A Strutynska, Oksana O Piven, Lidiia A Mys, Yulia V Goshovska, Raisa A Fedichkina, Iryna Y Okhai, Vladyslav R Strutynskyi, Victor E Dosenko, Pawel Dobrzyn, Vadim F Sagach
Upregulation of ATP-Sensitive Potassium Channels as the Potential Mechanism of Cardioprotection and Vasorelaxation Under the Action of Pyridoxal-5-Phosphate in Old Rats. Journal of cardiovascular pharmacology and therapeutics 28 (2023)
Qi Lou, Luyifei Li, Guangzhong Liu, Tiankai Li, Li Zhang, Yanxiang Zang, Chengchuang Zhan, Hong Wang, Weimin Li
Vericiguat reduces electrical and structural remodeling in a rabbit model of atrial fibrillation. Journal of cardiovascular pharmacology and therapeutics 28 (2023)
Qihong Liang, Lulan Li, Kerong Chen, Sheng An, Zhiya Deng, Jiaxin Li, Shiyu Zhou, Zhongqing Chen, Zhenhua Zeng, Sheng-Li An
Effect of Esmolol on Clinical Outcomes in Critically Ill Patients: Data from the MIMIC-IV Database. Journal of cardiovascular pharmacology and therapeutics 28 (2023)
Gerd Heusch
Cardioprotection and its Translation: A Need for New Paradigms? Or for New Pragmatism? An Opinionated Retro- and Perspective. Journal of cardiovascular pharmacology and therapeutics 28 (2023)
Rosaria Vincenza Giglio, Emir M Muzurović, Angelo Maria Patti, Peter P Toth, Manyoo A Agarwal, Wael Almahmeed, Aleksandra Klisic, Marcello Ciaccio, Manfredi Rizzo
Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i): Current Evidence for Expanding the Paradigm? Journal of cardiovascular pharmacology and therapeutics 28 (2023)
Zuo-Zhong Yu, Zheng-Xiong Xu, Yue-Hua Ruan, Long-Long Hu, Ming-Hua Wen, Tie-Qiu Huang, Zhi-Gang You, Yan-Qing Wu, Ren-Qiang Yang
Protective Effect of Nicorandil on Contrast-Induced Acute Kidney Injury After Emergency Percutaneous Coronary Intervention. Journal of cardiovascular pharmacology and therapeutics 28 (2023)
Vladimír Blaha, Roman Margoczy, Ivo Petrov, Arman Postadzhiyan, Katarína Rašlová, Hana Rosolová, Ian Bridges, Nafeesa N Dhalwani, Marie Zachlederova, Kausik K Ray
Evolocumab is Initiated in Central and Eastern Europe at Much Higher LDL-C Levels Than Recommended in Guidelines: Results from the Observational HEYMANS Study. Journal of cardiovascular pharmacology and therapeutics 28 (2023)

volume 27, 2022

Ariel Roguin, Ofer Kobo, Simcha Ron Meisel, Emad Maraga, Aaron Frimerman, Naama Amsalem, Rinat Malka, Yaniv Levi, Rami Abu Fanne
Morphine Use in ST-Elevation Myocardial Infarction With Downstream P 2 Y 12 Receptor Blockers-Insight From Observational Study. Journal of cardiovascular pharmacology and therapeutics 27 (2022)
Estefanny Villar-Matamoros, Lauren Stokes, Alyssa Lloret, Meagan Todd, Bryan W Tillman, Saami K Yazdani
Understanding the Mechanism of Drug Transfer and Retention of Drug-Coated Balloons. Journal of cardiovascular pharmacology and therapeutics 27 (2022)
Vitali Koch, Christophe Weber, Johannes H Riffel, Kristina Buchner, Sebastian J Buss, Selina Hein, Derliz Mereles, Marco Hagenmueller, Christian Erbel, Winfried März, Christian Booz, Moritz H Albrecht, Thomas J Vogl, Norbert Frey, Stefan E Hardt, Marco Ochs
Impact of Homoarginine on Myocardial Function and Remodeling in a Rat Model of Chronic Renal Failure. Journal of cardiovascular pharmacology and therapeutics 27 (2022)
Rui Zhang, Xiaotong Sun, Ya Li, Wenzheng He, Hongguang Zhu, Baoshan Liu, Aiyuan Zhang
The Efficacy and Safety of Sacubitril/Valsartan in Heart Failure Patients: A Review. Journal of cardiovascular pharmacology and therapeutics 27 (2022)
Po-Lin Lin, Ying-Hsiang Lee, Lawrence Yu-Min Liu, Cheng-Ting Tsai, Ten-Fang Yang, Wei-Ru Chiou, Mu-Yang Hsieh, Hung-Yu Chang, Chun-Che Huang
Duration of Heart Failure With Reduced Ejection Fraction Associated With Electrocardiographic Outcomes Before and After Sacubitril/Valsartan. Journal of cardiovascular pharmacology and therapeutics 27 (2022)
Itay Borreda, Robert Zukermann, Danny Epstein, Erez Marcusohn
IV Sodium Ferric Gluconate Complex in Patients Hospitalized Due to Acute Decompensated Heart Failure and Iron Deficiency. Journal of cardiovascular pharmacology and therapeutics 27 (2022)
Eliana Ferroni, Gentian Denas, Nicola Gennaro, Ugo Fedeli, Vittorio Pengo
Gender Related Differences in Gastrointestinal Bleeding With Oral Anticoagulation in Atrial Fibrillation. Journal of cardiovascular pharmacology and therapeutics 27 (2022)
Dannick Brochu, Amélie St-Arnaud, Louis-Étienne Marchand, Pierre Voisine, Julie Méthot
Impact of COVID-19 on the Prescribing Pattern of Oral Anticoagulants for Atrial Fibrillation After Cardiac Surgery. Journal of cardiovascular pharmacology and therapeutics 27 (2022)
Wasim S El Nekidy, Khalid Almuti, Hazem ElRefaei, Bassam Atallah, Lana M Mohammad, Wael AlMahmeed, Mohamed Badr, Khaled Abdallah, Fadi Hamed, Jihad Mallat
QT Prolongation in Critically Ill Patients With SARS-CoV-2 Infection. Journal of cardiovascular pharmacology and therapeutics 27 (2022)
Helmut Raphael Lieder, Pia Tüller, Felix Braczko, Afsaneh Zandi, Markus Kamler, Matthias Thielmann, Gerd Heusch, Petra Kleinbongard
Bioassays of Humoral Cardioprotective Factors Released by Remote Ischemic Conditioning in Patients Undergoing Coronary Artery Bypass Surgery. Journal of cardiovascular pharmacology and therapeutics 27 (2022)
Caroline Coppinger, Mohammad Reza Movahed, Veronica Azemawah, Lee Peyton, James Gregory, Mehrnoosh Hashemzadeh
A Comprehensive Review of PCSK9 Inhibitors. Journal of cardiovascular pharmacology and therapeutics 27 (2022)
Amalia Baroutidou, Anastasios Kartas, Athanasios Samaras, Andreas S Papazoglou, Eleni Vrana, Dimitrios V Moysidis, Evangelos Akrivos, Anastasios Papanastasiou, Ioannis Vouloagkas, Michail Botis, Evangelos Liampas, Artemios G Karagiannidis, Efstratios Karagiannidis, Georgios Efthimiadis, Haralambos Karvounis, Apostolos Tzikas, George Giannakoulas
Associations of Atrial Fibrillation Patterns With Mortality and Cardiovascular Events: Implications of the MISOAC-AF Trial. Journal of cardiovascular pharmacology and therapeutics 27 (2022)
Emir M Muzurović, Špela Volčanšek, Karin Zibar Tomšić, Andrej Janež, Dimitri P Mikhailidis, Manfredi Rizzo, Christos S Mantzoros
Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease-Current Evidence. Journal of cardiovascular pharmacology and therapeutics 27 (2022)
Emir M Muzurović, Špela Volčanšek, Karin Zibar Tomšić, Andrej Janež, Dimitri P Mikhailidis, Manfredi Rizzo, Christos S Mantzoros
Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease-Current Evidence. Journal of cardiovascular pharmacology and therapeutics 27 (2022)
Paolo Cimaglia, Davide Bernucci, Laura Sofia Cardelli, Anna Carone, Giuseppe Scavone, Marco Manfrini, Stefano Censi, Simone Calvi, Roberto Ferrari, Gianluca Campo, Luca Dalla Paola
Renin-Angiotensin-Aldosterone System Inhibitors, Statins, and Beta-Blockers in Diabetic Patients With Critical Limb Ischemia and Foot Lesions. Journal of cardiovascular pharmacology and therapeutics 27 (2022)
Eman El-Khateeb, Sahar Mohamed El-Haggar, Osama El-Razaky, Mohamed Ramadan El-Shanshory, Tarek Mohamed Mostafa
Randomized Clinical and Biochemical Study Comparing the Effect of L-arginine and Sildenafil in Beta Thalassemia Major Children With High Tricuspid Regurgitant Jet Velocity. Journal of cardiovascular pharmacology and therapeutics 27 (2022)
Patricia P Wadowski, Joseph Pultar, Constantin Weikert, Beate Eichelberger, Maximilian Tscharre, Renate Koppensteiner, Simon Panzer, Thomas Gremmel
Platelet-to-Lymphocyte Ratio as Marker of Platelet Activation in Patients on Potent P2Y 12 Inhibitors. Journal of cardiovascular pharmacology and therapeutics 27 (2022)
Wayne Kaesemeyer, Tatsiana Suvorava
Nitric Oxide Is the Cause of Nitroglycerin Tolerance: Providing an Old Dog New Tricks for Acute Heart Failure. Journal of cardiovascular pharmacology and therapeutics 27 (2022)
Alberico Luigi Catapano, Michal Vrablik, Yuri Karpov, Baptiste Berthou, Megan Loy, Marie Baccara-Dinet
A Phase 3 Randomized Controlled Trial to Evaluate Efficacy and Safety of New-Formulation Zenon (Rosuvastatin/Ezetimibe Fixed-Dose Combination) in Primary Hypercholesterolemia Inadequately Controlled by Statins. Journal of cardiovascular pharmacology and therapeutics 27 (2022)
Robert W Ariss, Rajesh Gupta
Estimated Aggregate Treatment Benefit With Addition of Multiple Novel Medications for Secondary Prevention of Atherosclerotic Cardiovascular Disease. Journal of cardiovascular pharmacology and therapeutics 27 (2022)
Jorge L Reyes, Charles A Herzog, Heng Yan, Nicholas S Roetker, James B Wetmore
Prescribing Patterns of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Retrospective Cohort Analysis. Journal of cardiovascular pharmacology and therapeutics 27 (2022)